Larisa Yeomans

592 total citations
25 papers, 453 citations indexed

About

Larisa Yeomans is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Oncology. According to data from OpenAlex, Larisa Yeomans has authored 25 papers receiving a total of 453 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 7 papers in Cellular and Molecular Neuroscience and 4 papers in Oncology. Recurrent topics in Larisa Yeomans's work include Receptor Mechanisms and Signaling (7 papers), Neuropeptides and Animal Physiology (7 papers) and Metabolomics and Mass Spectrometry Studies (6 papers). Larisa Yeomans is often cited by papers focused on Receptor Mechanisms and Signaling (7 papers), Neuropeptides and Animal Physiology (7 papers) and Metabolomics and Mass Spectrometry Studies (6 papers). Larisa Yeomans collaborates with scholars based in United States, China and Mexico. Larisa Yeomans's co-authors include Kathleen A. Stringer, Henry I. Mosberg, Jessica P. Anand, John R. Traynor, Emily M. Jutkiewicz, Katarzyna Sobczyk‐Kojiro, Frank Porreca, Edward J. Bilsky, Peg Davis and Robin Polt and has published in prestigious journals such as Journal of the American Chemical Society, SHILAP Revista de lepidopterología and Journal of Medicinal Chemistry.

In The Last Decade

Larisa Yeomans

24 papers receiving 446 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Larisa Yeomans United States 13 302 166 65 46 42 25 453
Christopher K. Arnatt United States 17 277 0.9× 131 0.8× 58 0.9× 16 0.3× 69 1.6× 46 543
Sharat Chandra India 13 209 0.7× 53 0.3× 64 1.0× 42 0.9× 27 0.6× 25 387
Albane Kessler France 11 294 1.0× 123 0.7× 71 1.1× 33 0.7× 117 2.8× 13 550
Paola Misiano Italy 12 254 0.8× 54 0.3× 32 0.5× 18 0.4× 38 0.9× 20 481
Mark Holbrook United Kingdom 15 262 0.9× 63 0.4× 85 1.3× 12 0.3× 19 0.5× 22 558
Margaret E. McCann United States 14 236 0.8× 46 0.3× 65 1.0× 32 0.7× 61 1.5× 19 550
Therese Ku United States 13 129 0.4× 81 0.5× 38 0.6× 22 0.5× 58 1.4× 18 412
Katayoun Derakhchan United States 11 183 0.6× 39 0.2× 65 1.0× 52 1.1× 51 1.2× 20 647
B. Bindukumar United States 9 174 0.6× 66 0.4× 27 0.4× 27 0.6× 11 0.3× 9 460
Rebecca Fransson Sweden 13 174 0.6× 102 0.6× 100 1.5× 10 0.2× 126 3.0× 23 401

Countries citing papers authored by Larisa Yeomans

Since Specialization
Citations

This map shows the geographic impact of Larisa Yeomans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Larisa Yeomans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Larisa Yeomans more than expected).

Fields of papers citing papers by Larisa Yeomans

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Larisa Yeomans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Larisa Yeomans. The network helps show where Larisa Yeomans may publish in the future.

Co-authorship network of co-authors of Larisa Yeomans

This figure shows the co-authorship network connecting the top 25 collaborators of Larisa Yeomans. A scholar is included among the top collaborators of Larisa Yeomans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Larisa Yeomans. Larisa Yeomans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bongers, Kale S., Larisa Yeomans, Nicole R. Falkowski, et al.. (2025). Gut microbiome-mediated nutrients alter opportunistic bacterial growth in peritonitis. American Journal of Physiology-Gastrointestinal and Liver Physiology. 329(6). G747–G758. 1 indexed citations
2.
Yeomans, Larisa, et al.. (2024). Identification of a selective pyruvate dehydrogenase kinase 1 (PDHK1) chemical probe by virtual screening. European Journal of Medicinal Chemistry. 284. 117210–117210. 1 indexed citations
3.
Rajeswaran, Walajapet G., Pil H. Lee, Larisa Yeomans, et al.. (2022). Optimization of Benzoxazinorifamycins to Improve Mycobacterium tuberculosis RNA Polymerase Inhibition and Treatment of Tuberculosis. ACS Infectious Diseases. 8(8). 1422–1438. 4 indexed citations
4.
Shi, Jiaqi, Lili Zhao, Alexander Raskind, et al.. (2021). Cyst fluid metabolites distinguish malignant from benign pancreatic cysts. Neoplasia. 23(11). 1078–1088. 10 indexed citations
5.
Ward, Kristen M., Kyle J. Burghardt, A. Zarina Kraal, et al.. (2021). Genetic and Metabolite Variability in One-Carbon Metabolism Applied to an Insulin Resistance Model in Patients With Schizophrenia Receiving Atypical Antipsychotics. Frontiers in Psychiatry. 12. 623143–623143. 2 indexed citations
6.
Ambroggio, Lilliam, Todd A. Florin, Kayla Williamson, et al.. (2021). Respiratory Colonization and Short-Term Temporal Changes in the Urinary Metabolome of Children. Metabolites. 11(8). 500–500. 1 indexed citations
7.
Liu, Xuwen, Michael W. Wilson, Kun Liu, et al.. (2020). Synthesis and structure-activity relationships of thieno[2,3-d]pyrimidines as atypical protein kinase C inhibitors to control retinal vascular permeability and cytokine-induced edema. Bioorganic & Medicinal Chemistry. 28(11). 115480–115480. 1 indexed citations
8.
Yeomans, Larisa, Jun Hyung Kim, Ping Xiang, et al.. (2019). Disruption of histidine and energy homeostasis in chronic obstructive pulmonary disease. SHILAP Revista de lepidopterología. 1 indexed citations
9.
Labaki, Wassim W., MeiLan K. Han, Larisa Yeomans, et al.. (2019). <p>Disruption of histidine and energy homeostasis in chronic obstructive pulmonary disease</p>. International Journal of COPD. Volume 14. 2015–2025. 20 indexed citations
10.
Sun, Yihan, Daniel F. Hayes, Elizabeth Smith, et al.. (2018). Pharmacometabolomics reveals a role for histidine, phenylalanine, and threonine in the development of paclitaxel-induced peripheral neuropathy. Breast Cancer Research and Treatment. 171(3). 657–666. 29 indexed citations
11.
Keswani, Rahul K., Larisa Yeomans, Victor Vitvitsky, et al.. (2016). Macrophage-Mediated Clofazimine Sequestration Is Accompanied by a Shift in Host Energy Metabolism. Journal of Pharmaceutical Sciences. 106(4). 1162–1174. 20 indexed citations
12.
Stringer, Kathleen A., John G. Younger, Larisa Yeomans, et al.. (2015). Whole Blood Reveals More Metabolic Detail of the Human Metabolome than Serum as Measured by 1H-NMR Spectroscopy. Shock. 44(3). 200–208. 55 indexed citations
13.
Andrea, T., Kathleen A. Stringer, José A. Díaz, et al.. (2015). 1D-1H-nuclear magnetic resonance metabolomics reveals age-related changes in metabolites associated with experimental venous thrombosis. Journal of Vascular Surgery Venous and Lymphatic Disorders. 4(2). 221–230. 19 indexed citations
14.
Yeomans, Larisa, Nicholas W. Griggs, Jessica P. Anand, et al.. (2015). Further Optimization and Evaluation of Bioavailable, Mixed-Efficacy μ-Opioid Receptor (MOR) Agonists/δ-Opioid Receptor (DOR) Antagonists: Balancing MOR and DOR Affinities. Journal of Medicinal Chemistry. 58(22). 8952–8969. 34 indexed citations
15.
Mosberg, Henry I., Larisa Yeomans, Jessica P. Anand, et al.. (2014). Development of a Bioavailable μ Opioid Receptor (MOPr) Agonist, δ Opioid Receptor (DOPr) Antagonist Peptide That Evokes Antinociception without Development of Acute Tolerance. Journal of Medicinal Chemistry. 57(7). 3148–3153. 51 indexed citations
16.
Mosberg, Henry I., Larisa Yeomans, Aaron M. Bender, et al.. (2013). Opioid Peptidomimetics: Leads for the Design of Bioavailable Mixed Efficacy μ Opioid Receptor (MOR) Agonist/δ Opioid Receptor (DOR) Antagonist Ligands. Journal of Medicinal Chemistry. 56(5). 2139–2149. 44 indexed citations
17.
Yeomans, Larisa, M. Dhanasekaran, John J. Lowery, et al.. (2011). Phosphorylation of Enkephalins: NMR and CD Studies in Aqueous and Membrane‐Mimicking Environments. Chemical Biology & Drug Design. 78(5). 749–756. 4 indexed citations
18.
Lowery, John J., Larisa Yeomans, Peg Davis, et al.. (2007). Glycosylation Improves the Central Effects of DAMGO. Chemical Biology & Drug Design. 69(1). 41–47. 36 indexed citations
19.
Dhanasekaran, M., Michael M. Palian, Isabel D. Alves, et al.. (2005). Glycopeptides Related to β-Endorphin Adopt Helical Amphipathic Conformations in the Presence of Lipid Bilayers. Journal of the American Chemical Society. 127(15). 5435–5448. 32 indexed citations
20.
Muñı́z, Jesús, Larisa Yeomans, L. F. del Castillo, et al.. (1996). Electrostatic forces as a possible mechanism underlying skeletal muscle contraction.. PubMed. 15(6). 441–9.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026